Aspira Women's Health Past Earnings Performance
Past criteria checks 0/6
Aspira Women's Health's earnings have been declining at an average annual rate of -6.6%, while the Medical Equipment industry saw earnings declining at 1.1% annually. Revenues have been growing at an average rate of 18.5% per year.
Key information
-6.6%
Earnings growth rate
2.1%
EPS growth rate
| Medical Equipment Industry Growth | 4.3% |
| Revenue growth rate | 18.5% |
| Return on equity | n/a |
| Net Margin | -178.8% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Aspira Women's Health makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 9 | -16 | 19 | 4 |
| 31 Mar 24 | 9 | -15 | 19 | 4 |
| 31 Dec 23 | 9 | -17 | 20 | 4 |
| 30 Sep 23 | 9 | -18 | 21 | 4 |
| 30 Jun 23 | 9 | -21 | 24 | 5 |
| 31 Mar 23 | 9 | -27 | 27 | 6 |
| 31 Dec 22 | 8 | -30 | 30 | 6 |
| 30 Sep 22 | 8 | -34 | 33 | 6 |
| 30 Jun 22 | 7 | -36 | 34 | 6 |
| 31 Mar 22 | 7 | -35 | 34 | 6 |
| 31 Dec 21 | 7 | -32 | 30 | 5 |
| 30 Sep 21 | 6 | -29 | 27 | 5 |
| 30 Jun 21 | 6 | -23 | 23 | 4 |
| 31 Mar 21 | 5 | -20 | 19 | 3 |
| 31 Dec 20 | 5 | -18 | 17 | 2 |
| 30 Sep 20 | 5 | -15 | 15 | 2 |
| 30 Jun 20 | 5 | -15 | 15 | 1 |
| 31 Mar 20 | 5 | -15 | 16 | 1 |
| 31 Dec 19 | 5 | -15 | 15 | 1 |
| 30 Sep 19 | 4 | -15 | 15 | 1 |
| 30 Jun 19 | 4 | -14 | 13 | 1 |
| 31 Mar 19 | 3 | -12 | 12 | 1 |
| 31 Dec 18 | 3 | -11 | 11 | 1 |
| 30 Sep 18 | 3 | -12 | 11 | 1 |
| 30 Jun 18 | 3 | -12 | 10 | 1 |
| 31 Mar 18 | 3 | -12 | 10 | 1 |
| 31 Dec 17 | 3 | -11 | 10 | 1 |
| 30 Sep 17 | 3 | -11 | 10 | 1 |
| 30 Jun 17 | 3 | -11 | 10 | 1 |
| 31 Mar 17 | 3 | -13 | 11 | 1 |
| 31 Dec 16 | 3 | -15 | 13 | 2 |
| 30 Sep 16 | 2 | -17 | 14 | 3 |
| 30 Jun 16 | 2 | -19 | 15 | 3 |
| 31 Mar 16 | 2 | -20 | 16 | 4 |
| 31 Dec 15 | 2 | -19 | 15 | 4 |
| 30 Sep 15 | 3 | -18 | 15 | 4 |
| 30 Jun 15 | 3 | -19 | 16 | 4 |
| 31 Mar 15 | 3 | -19 | 16 | 5 |
| 31 Dec 14 | 3 | -19 | 16 | 5 |
| 30 Sep 14 | 3 | -17 | 14 | 4 |
| 30 Jun 14 | 3 | -14 | 12 | 4 |
| 31 Mar 14 | 3 | -10 | 9 | 3 |
| 31 Dec 13 | 3 | -9 | 9 | 3 |
Quality Earnings: CUL is currently unprofitable.
Growing Profit Margin: CUL is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: CUL is unprofitable, and losses have increased over the past 5 years at a rate of 6.6% per year.
Accelerating Growth: Unable to compare CUL's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: CUL is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (16.2%).
Return on Equity
High ROE: CUL's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.